Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland
ClinicalTrials.gov Identifier:
NCT01527279
First received: February 2, 2012
Last updated: May 21, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)